ROIVRoivant Sciences Ltd.

$37.00+187% 1Y

RyuScore

Seven criteria, each scored 0 to 100 on a published scale, weighted into one number.

RyuScore 42 out of 100, Below average

Below average. Roivant Sciences Ltd. scores higher than 32% of the 1,794 companies Ryufin scores.

Carried by return on capital and return on new capital, held back by valuation and capital allocation.

Healthcare median 29 · all companies 57

How the score has moved

At each fiscal year end, from the reports and price of the time
77
40
42
42
202320242025today

The biggest move was down 37 points from 2023 to 2024, mostly valuation.

Valuation

26% of the score, 30% here after data gaps

0median 56

An operating loss over the last year: there are no earnings to price.

Return on capital

18% of the score, 20% here after data gaps

100median 34

Over 5 years the business earned 29% a year after tax on the capital it uses.

2%
8%
15%
25%
29%
None at 2% or less, full points from 25%full points
Return on capital by year
5 years agolatest -67%

Return on new capital

16% of the score, 18% here after data gaps

100median 49

For every dollar of operating profit earned over 6 years, yearly profit grew by 65 cents. New capital earned 103%, and 63% of profit went back into the business.

-5%
12%
65%
None at minus 5 cents, full points from 12 centsfull points

Capital allocation

14% of the score, 16% here after data gaps

23median 67

How management spends the money: shares bought back or issued, and whether assets grow faster than the business they serve.

Share countUp 1.9% a year over 5 years: new shares
38
5%
-3%
1.9%
0 pointsfull points
Assets against salesAssets grew 17% a year, sales -19%
0
12%
-2%
36%
0 pointsfull points

Cycle position

Taken out: its 12% is shared by the others

n/ano data

Margins have been too thin to measure a cycle against.

Balance sheet

8% of the score, 9% here after data gaps

0median 50

What the debt weighs against the profit that has to carry it.

Interest coverAn operating loss: the interest is not covered
0
1.5x
12x
-17.1x
0 pointsfull points

Earnings quality

6% of the score, 7% here after data gaps

0median 90

Whether the reported profit arrives as cash, and whether the accounts show the usual signs of stretching.

Cash against profitOperating cash flow was -0.61x profit over 3 years
0
0.7x
1x
1.3x
-0.6x
0 pointsfull points
AccrualsProfit ran ahead of cash by 8.1% of assets
0
8%
0%
-8%
8.1%
0 pointsfull points

How the RyuScore works

Each criterion earns 0 to 100 points on the scale drawn under it, and the RyuScore is their average weighted 26, 18, 16, 14, 12, 8 and 6. Scales bend in the company's favour between their ends, so an ordinary figure is never already near zero. For ROIV, cycle position could not be measured from the filings, so it is taken out and the remaining weights scale up.

Built from the company's annual and quarterly filings with the SEC and today's share price. Banks, insurers and property trusts are not scored: their debt is their raw material, so these yardsticks mean something else there. Figures as of 2026-06-30, latest annual report FY2025.